A01886 Anti-Adalimumab Antibody, pAb, Rabbit
A01886 Anti-Adalimumab Antibody, pAb, Rabbit
The product is specific for Adalimumab. This antibody serves as an excellent positive control for Adalimumab The product is specific for Adalimumab. This antibody serves as an excellent positive control for Adalimumab immunogenicity (ADA) assays.
产品概述
| Specificity | The product is specific for Adalimumab. This antibody serves as an excellent positive control for Adalimumab The product is specific for Adalimumab. This antibody serves as an excellent positive control for Adalimumab immunogenicity (ADA) assays. |
| Host Species | Rabbit |
| Immunogen | Adalimumab |
| Conjugate | Unconjugated |
应用指导
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentration may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||
| |||||
产品属性
| Form | Lyophilized |
| Storage Buffer | lyophilized with PBS, pH 7.4, containing 0.02% sodium azide. |
| Reconstitution | Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/mL. |
| Storage Instructions | The lyophilized product remains stable for 1 year at -20℃ from the date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8℃ or for 12 months at -20℃ or below. Avoid repeated freezing and thawing cycles. |
| Purification | Antigen affinity purification |
| Isotype | Rabbit IgG |
| Clonality | Polyclonal |
| Clone ID | Not applicable |
| Note | GenScript can customize this product per customer's request including product size, buffer components, etc. |
技术背景
| Target Background | Adalimumab (Humira) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis. Adalimumab binds to the TNFα (tumor necrosis factor-alpha), and blocks its interaction with TNFα receptors, reducing the inflammatory response of autoimmune diseases.GenScript Anti-Adalimumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Adalimumab. |
| Synonyms | Rabbit polyclonal to Humira, Exemptia |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
